Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery

@article{Coln2016TamoxifenAF,
  title={Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery},
  author={J. M. Col{\'o}n and J. Miranda},
  journal={Neural Regeneration Research},
  year={2016},
  volume={11},
  pages={1208 - 1211}
}
Spinal cord injury (SCI) is a condition without a cure, affecting sensory and/or motor functions. The physical trauma to the spinal cord initiates a cascade of molecular and cellular events that generates a non-permissive environment for cell survival and axonal regeneration. Among these complex set of events are damage of the blood-brain barrier, edema formation, inflammation, oxidative stress, demyelination, reactive gliosis and apoptosis. The multiple events activated after SCI require a… Expand
Hormonal therapy in traumatic spinal cord injury.
Nanofiber Scaffolds as Drug Delivery Systems to Bridge Spinal Cord Injury
Eriodictyol corrects functional recovery and myelin loss in SCI rats
Huangqin flavonoid extraction for spinal cord injury in a rat model
Aldehyde dehydrogenase 2 overexpression inhibits neuronal apoptosis after spinal cord ischemia/reperfusion injury
...
1
2
3
...

References

SHOWING 1-10 OF 13 REFERENCES
The cancer drug tamoxifen: a potential therapeutic treatment for spinal cord injury.
Neuroprotective effects of tamoxifen on experimental spinal cord injury in rats
Sexual dimorphism in the spontaneous recovery from spinal cord injury: a gender gap in beneficial autoimmunity?
...
1
2
...